back to top
HomeMarketInfographic: Key highlights from Nio’s (NIO) Q2 2024 earnings outcomes | AlphaStreet

Infographic: Key highlights from Nio’s (NIO) Q2 2024 earnings outcomes | AlphaStreet

-

NIO Inc. (NYSE: NIO) reported its second quarter 2024 earnings outcomes right this moment.

Complete revenues have been $2.40 billion, up 98.9% from the identical interval final 12 months.

Web loss attributable to peculiar shareholders was $705.4 million, down 16.3% from final 12 months. Adjusted web loss attributable to peculiar shareholders was $623.7 million.

Web loss per peculiar share/ADS was $0.34. Adjusted loss per share/ADS was $0.30.

Car deliveries have been 57,373 within the second quarter of 2024, up 143.9% from final 12 months.

For the third quarter of 2024, the corporate expects complete revenues to vary between $2.63 billion and $2.70 billion, representing a rise of approx. 0.2% to three.2% from the prior-year interval. Deliveries of automobiles are anticipated to be between 61,000 and 63,000 models, representing a rise of approx. 10.0-13.7% from final 12 months.

Prior efficiency

LEAVE A REPLY

Please enter your comment!
Please enter your name here

CAPTCHA


LATEST POSTS

If the inventory market crashes, I'll purchase this surging FTSE 100 inventory instantly 

Picture supply: Getty Pictures Traditionally, there have been important inventory market crashes in September...

Will Bitcoin’s realized value drop to $31K? Ranges to watch

BTC has dropped beneath its 200-day shifting common for the second time, the primary being July 2024. An analyst predicted a drop to BTC’s realized value...

eToro buying and selling: U.S. shoppers restricted to BTC, ETH, BCH put up SEC deal

eToro buying and selling platform will limit U.S. crypto trades to Bitcoin, Ethereum, and Bitcoin Money following a settlement with the SEC. The SEC has fined...

Celularity pronounces government departure By Investing.com

Celularity Inc. (NASDAQ:CELU), a biotechnology firm specializing in pharmaceutical preparations, introduced the resignation of its Chief Medical Officer, Adrian Kilcoyne, M.D., M.P.H., M.B.A. Dr. Kilcoyne...

Most Popular